In this work, we analyzed only the patients of the NSTEMI (non ST-segment elevation myocardial infarction) who arrived at the hospital within 12 h after symptoms started. Using NSTEMI follow-up data within, the charac...In this work, we analyzed only the patients of the NSTEMI (non ST-segment elevation myocardial infarction) who arrived at the hospital within 12 h after symptoms started. Using NSTEMI follow-up data within, the characteristics of the clinical data, the risk factor, and the blood tested in the hospital visit were analyzed for MACE (major adverse cardiac events) patients. MACE includes cardiac death, MI (myocardial infarction), Re-PCI, and CABG (coronary artery bypass graft). As a result, from the NSTEMI patients which can be followed up for over 12 m, NT-ProBNP (p=0.014) and age (p=0.045) are found to be the independent risk factors related to MACE. Accordingly, they can be useful for the diagnosis and prognosis for NSTEMI patients as a biomarker.展开更多
Background and Objective Elevated serum levels of lipoprotein(Lp[a]) has recently been proposed as a marker of cardiovascular risk.We aimed to determine the role of Lp(a) on long-term clinical outcomes in patients wit...Background and Objective Elevated serum levels of lipoprotein(Lp[a]) has recently been proposed as a marker of cardiovascular risk.We aimed to determine the role of Lp(a) on long-term clinical outcomes in patients with ST elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).展开更多
目的分析非ST段抬高型心肌梗死(non-ST-segment elevation myocardial infarction,NSTEMI)患者和ST段抬高型心肌梗死(ST-elevated myocardial infarction,STEMI)患者血小板与淋巴细胞比值(platelet to lymphocyte ratio,PLR)、中性粒细...目的分析非ST段抬高型心肌梗死(non-ST-segment elevation myocardial infarction,NSTEMI)患者和ST段抬高型心肌梗死(ST-elevated myocardial infarction,STEMI)患者血小板与淋巴细胞比值(platelet to lymphocyte ratio,PLR)、中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)、淋巴细胞与单核细胞比值(lymphocyte to monocyte ratio,LMR)及凝血功能指标检测的意义。方法选择2021年1月至2023年12月蚌埠市第三人民医院心血管内科收治的老年(>60岁)急性心肌梗死患者182例,根据心电图特征分为NSTEMI组104例和STEMI组78例,另选取同期于蚌埠市第三人民医院体检的健康者80例作为对照组。入院后检测所有受试者的PLR、NLR、LMR、D-二聚体及纤维蛋白原(fibrinogen,FIB)水平。对比3组血清PLR、NLR、LMR、D-二聚体、FIB水平,采用二元logistic回归分析法构建基于PLR、NLR、LMR、D-二聚体、FIB的评估模型,以ROC曲线分析PLR、NLR、LMR、D-二聚体、FIB评估NSTEMI与STEMI患者的价值。结果STEMI组和NSTEMI组的血清PLR、NLR、LMR、D-二聚体、FIB水平明显高于对照组(P<0.05)。血清PLR、NLR、LMR、D-二聚体、FIB水平为STEMI和NSTEMI患者的独立影响因子(OR=25.078,95%CI:3.147~199.865;OR=32.852,95%CI:4.398~245.417;OR=28.703,95%CI:3.310~248.867,OR=67.491,95%CI:8.518~534.729;OR=46.759,95%CI:8.219~266.006;OR=2.573,95%CI:1.026~6.451;OR=3.442,95%CI:1.750~6.768,OR=2.971,95%CI:1.799~4.907;OR=68.375,95%CI:12.598~371.103;OR=7.471,95%CI:1.759~31.737,P<0.01)。ROC曲线显示,血清PLR、NLR、LMR、D-二聚体、FIB联合评估NSTEMI的曲线下面积(area under curve,AUC)为0.996,敏感性为99.04%,特异性为95.00%;联合评估STEMI的AUC为0.995,敏感性为94.87%,特异性为97.50%,效能优于各指标单独评估(P<0.05)。结论NSTEMI患者与STEMI患者的PLR、NLR、LMR、D-二聚体、FIB水平明显升高,各指标联合测定对于NSTEMI和STEMI的早期诊断具有重要的参考价值。展开更多
基金Project(2012-0000478) supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST)
文摘In this work, we analyzed only the patients of the NSTEMI (non ST-segment elevation myocardial infarction) who arrived at the hospital within 12 h after symptoms started. Using NSTEMI follow-up data within, the characteristics of the clinical data, the risk factor, and the blood tested in the hospital visit were analyzed for MACE (major adverse cardiac events) patients. MACE includes cardiac death, MI (myocardial infarction), Re-PCI, and CABG (coronary artery bypass graft). As a result, from the NSTEMI patients which can be followed up for over 12 m, NT-ProBNP (p=0.014) and age (p=0.045) are found to be the independent risk factors related to MACE. Accordingly, they can be useful for the diagnosis and prognosis for NSTEMI patients as a biomarker.
文摘Background and Objective Elevated serum levels of lipoprotein(Lp[a]) has recently been proposed as a marker of cardiovascular risk.We aimed to determine the role of Lp(a) on long-term clinical outcomes in patients with ST elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).
文摘目的分析非ST段抬高型心肌梗死(non-ST-segment elevation myocardial infarction,NSTEMI)患者和ST段抬高型心肌梗死(ST-elevated myocardial infarction,STEMI)患者血小板与淋巴细胞比值(platelet to lymphocyte ratio,PLR)、中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)、淋巴细胞与单核细胞比值(lymphocyte to monocyte ratio,LMR)及凝血功能指标检测的意义。方法选择2021年1月至2023年12月蚌埠市第三人民医院心血管内科收治的老年(>60岁)急性心肌梗死患者182例,根据心电图特征分为NSTEMI组104例和STEMI组78例,另选取同期于蚌埠市第三人民医院体检的健康者80例作为对照组。入院后检测所有受试者的PLR、NLR、LMR、D-二聚体及纤维蛋白原(fibrinogen,FIB)水平。对比3组血清PLR、NLR、LMR、D-二聚体、FIB水平,采用二元logistic回归分析法构建基于PLR、NLR、LMR、D-二聚体、FIB的评估模型,以ROC曲线分析PLR、NLR、LMR、D-二聚体、FIB评估NSTEMI与STEMI患者的价值。结果STEMI组和NSTEMI组的血清PLR、NLR、LMR、D-二聚体、FIB水平明显高于对照组(P<0.05)。血清PLR、NLR、LMR、D-二聚体、FIB水平为STEMI和NSTEMI患者的独立影响因子(OR=25.078,95%CI:3.147~199.865;OR=32.852,95%CI:4.398~245.417;OR=28.703,95%CI:3.310~248.867,OR=67.491,95%CI:8.518~534.729;OR=46.759,95%CI:8.219~266.006;OR=2.573,95%CI:1.026~6.451;OR=3.442,95%CI:1.750~6.768,OR=2.971,95%CI:1.799~4.907;OR=68.375,95%CI:12.598~371.103;OR=7.471,95%CI:1.759~31.737,P<0.01)。ROC曲线显示,血清PLR、NLR、LMR、D-二聚体、FIB联合评估NSTEMI的曲线下面积(area under curve,AUC)为0.996,敏感性为99.04%,特异性为95.00%;联合评估STEMI的AUC为0.995,敏感性为94.87%,特异性为97.50%,效能优于各指标单独评估(P<0.05)。结论NSTEMI患者与STEMI患者的PLR、NLR、LMR、D-二聚体、FIB水平明显升高,各指标联合测定对于NSTEMI和STEMI的早期诊断具有重要的参考价值。
